应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
SPRO Spero Therapeutics Inc.
未开盘 11-21 16:00:00 EST
1.19
-0.01
-0.83%
盘后
1.16
-0.03
-2.50%
19:31 EST
最高
1.21
最低
1.15
成交量
19.55万
今开
1.19
昨收
1.20
日振幅
5.00%
总市值
6,432万
流通市值
4,770万
总股本
5,405万
成交额
23.17万
换手率
0.49%
流通股本
4,009万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Spero Therapeutics, Inc.盘中异动 快速上涨5.12%
市场透视 · 11-21 03:05
Spero Therapeutics, Inc.盘中异动 快速上涨5.12%
Spero Therapeutics, Inc.盘中异动 下午盘急速下跌5.08%
市场透视 · 11-19
Spero Therapeutics, Inc.盘中异动 下午盘急速下跌5.08%
Spero Therapeutics, Inc.盘中异动 急速跳水6.11%报1.23美元
市场透视 · 11-15
Spero Therapeutics, Inc.盘中异动 急速跳水6.11%报1.23美元
Spero Therapeutics Inc 预计每股亏损 36 美分 - 财报前瞻
Reuters · 11-08
Spero Therapeutics Inc 预计每股亏损 36 美分 - 财报前瞻
Spero Therapeutics, Inc.盘中异动 早盘股价大涨5.93%报1.25美元
市场透视 · 11-04
Spero Therapeutics, Inc.盘中异动 早盘股价大涨5.93%报1.25美元
Spero Therapeutics, Inc.盘中异动 大幅跳水5.43%报1.22美元
市场透视 · 10-31
Spero Therapeutics, Inc.盘中异动 大幅跳水5.43%报1.22美元
Spero Therapeutics, Inc.盘中异动 快速跳水19.85%报1.05美元
市场透视 · 10-30
Spero Therapeutics, Inc.盘中异动 快速跳水19.85%报1.05美元
Spero Therapeutics, Inc.盘中异动 股价大涨5.56%报1.33美元
市场透视 · 10-26
Spero Therapeutics, Inc.盘中异动 股价大涨5.56%报1.33美元
Spero Therapeutics, Inc.盘中异动 下午盘快速上涨5.24%
市场透视 · 10-18
Spero Therapeutics, Inc.盘中异动 下午盘快速上涨5.24%
Spero Therapeutics, Inc.盘中异动 早盘大幅跳水5.38%
市场透视 · 10-08
Spero Therapeutics, Inc.盘中异动 早盘大幅跳水5.38%
Spero Therapeutics, Inc.盘中异动 早盘急速上涨5.47%报1.35美元
市场透视 · 09-27
Spero Therapeutics, Inc.盘中异动 早盘急速上涨5.47%报1.35美元
Spero Therapeutics, Inc.盘中异动 急速上涨5.04%报1.25美元
自选股智能写手 · 08-19
Spero Therapeutics, Inc.盘中异动 急速上涨5.04%报1.25美元
Spero Therapeutics, Inc.2024财年第二财季实现净利润-17.86百万美元,同比减少49.96%
自选股智能写手 · 08-12
Spero Therapeutics, Inc.2024财年第二财季实现净利润-17.86百万美元,同比减少49.96%
TD Cowen:上调Spero Therapeutics(SPRO.US)评级,由持有调整至买入评级。
智通财经 · 08-07
TD Cowen:上调Spero Therapeutics(SPRO.US)评级,由持有调整至买入评级。
Spero Therapeutics, Inc.盘中异动 早盘股价大跌5.22%报1.27美元
自选股智能写手 · 08-06
Spero Therapeutics, Inc.盘中异动 早盘股价大跌5.22%报1.27美元
Spero Therapeutics, Inc.盘中异动 下午盘快速上涨6.52%报1.47美元
自选股智能写手 · 07-26
Spero Therapeutics, Inc.盘中异动 下午盘快速上涨6.52%报1.47美元
Spero Therapeutics, Inc.盘中异动 临近收盘股价大跌5.41%
自选股智能写手 · 07-19
Spero Therapeutics, Inc.盘中异动 临近收盘股价大跌5.41%
Spero Therapeutics, Inc.盘中异动 股价大涨5.19%
自选股智能写手 · 07-17
Spero Therapeutics, Inc.盘中异动 股价大涨5.19%
Spero Therapeutics, Inc.盘中异动 临近午盘大幅上涨6.62%
自选股智能写手 · 07-11
Spero Therapeutics, Inc.盘中异动 临近午盘大幅上涨6.62%
Spero Therapeutics, Inc.盘中异动 快速上涨5.91%
自选股智能写手 · 07-10
Spero Therapeutics, Inc.盘中异动 快速上涨5.91%
公司概况
公司名称:
Spero Therapeutics Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Spero Therapeutics, Inc.,前称为Spero Therapeutics,LLC,于2013年12月根据特拉华州的法律成立。该公司是一个多资产,临床阶段的生物制药公司,专注于识别、开发和营销治疗MDR细菌感染的新疗法。该公司还拥有一项名为“潜力平台”的平台技术,他们相信这将使他们开发出能够扩大现有抗生素的范围和效力的药物,包括以前不活跃的抗生素,对抗革兰氏阴性细菌。他们相信,如果成功地开发和批准了他们的新产品,将会对社区和医院环境中治疗MDR感染的患者产生有意义的影响和重要的商业应用。
发行价格:
--
{"stockData":{"symbol":"SPRO","market":"US","secType":"STK","nameCN":"Spero Therapeutics Inc.","latestPrice":1.19,"timestamp":1732222800000,"preClose":1.2,"halted":0,"volume":195487,"hourTrading":{"tag":"盘后","latestPrice":1.1602,"preClose":1.19,"latestTime":"19:31 EST","volume":2055,"amount":2384.4,"timestamp":1732235491148},"delay":0,"floatShares":40086122,"shares":54049139,"eps":0.0602,"marketStatus":"未开盘","marketStatusCode":0,"change":-0.01,"latestTime":"11-21 16:00:00 EST","open":1.19,"high":1.21,"low":1.15,"amount":231687.9668645,"amplitude":0.05,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.0602,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732266000000},"adr":0,"listingDate":1509595200000,"adjPreClose":1.2,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":1.1826,"preClose":1.2,"latestTime":"08:14 EST","volume":110,"amount":131.716002,"timestamp":1732194851583},"postHourTrading":{"tag":"盘后","latestPrice":1.1602,"preClose":1.19,"latestTime":"19:31 EST","volume":2055,"amount":2384.4,"timestamp":1732235491148},"volumeRatio":0.525311,"impliedVol":1.4411,"impliedVolPercentile":0.6944},"requestUrl":"/m/hq/s/SPRO/wiki","defaultTab":"wiki","newsList":[{"id":"2485912139","title":"Spero Therapeutics, Inc.盘中异动 快速上涨5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485912139","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485912139?lang=zh_cn&edition=full","pubTime":"2024-11-21 03:05","pubTimestamp":1732129545,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日03时05分,Spero Therapeutics, Inc.股票出现异动,股价急速拉升5.12%。Spero Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.22%。其相关个股中,Forte Biosciences, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Exicure, Inc.涨幅较大,Forte Biosciences, Inc.、Silexion Therapeutics Corp、Exicure, Inc.较为活跃,换手率分别为1845.78%、1318.25%、952.81%,振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Forte Biosciences, Inc.、Exicure, Inc.,振幅分别为185.64%、169.09%、136.94%。Spero Therapeutics, Inc.公司简介:Spero Therapeutics Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121030545a2493852&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121030545a2493852&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRO","LENZ"],"gpt_icon":0},{"id":"2484041976","title":"Spero Therapeutics, Inc.盘中异动 下午盘急速下跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484041976","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484041976?lang=zh_cn&edition=full","pubTime":"2024-11-19 02:19","pubTimestamp":1731953962,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日02时19分,Spero Therapeutics, Inc.股票出现波动,股价快速跳水5.08%。Spero Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.01%。Spero Therapeutics, Inc.公司简介:Spero Therapeutics Inc是一家临床阶段生物制药公司。该公司的候选产品tebipenem pivoxil hydrobromide或tebipenem HBr,是一种口服碳青霉烯类抗生素,用于成人治疗MDR革兰氏阴性菌感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119021922abcd0dd2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119021922abcd0dd2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRO","LENZ","BK4139"],"gpt_icon":0},{"id":"2483738405","title":"Spero Therapeutics, Inc.盘中异动 急速跳水6.11%报1.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483738405","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483738405?lang=zh_cn&edition=full","pubTime":"2024-11-15 01:13","pubTimestamp":1731604382,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日01时13分,Spero Therapeutics, Inc.股票出现异动,股价大幅跳水6.11%。Spero Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.68%。其相关个股中,Molecular Templates, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、奥麦罗制药涨幅较大,Molecular Templates, Inc.、Elevai Labs, Inc.、Pulmatrix, Inc.较为活跃,换手率分别为3406.72%、3163.20%、360.18%,振幅较大的相关个股有Molecular Templates, Inc.、Pulmatrix, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029,振幅分别为249.67%、112.92%、86.36%。Spero Therapeutics, Inc.公司简介:Spero Therapeutics Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111501130298e42b4b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111501130298e42b4b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","SPRO"],"gpt_icon":0},{"id":"2481673483","title":"Spero Therapeutics Inc 预计每股亏损 36 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2481673483","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481673483?lang=zh_cn&edition=full","pubTime":"2024-11-08 23:49","pubTimestamp":1731080962,"startTime":"0","endTime":"0","summary":" * Spero Therapeutics Inc 预计将在 11 月 14 日公布截至 0001 年 1 月 1 日的季度收入报告。* 根据LSEG的数据,3位分析师的平均预期显示,这家总部位于马萨诸塞州剑桥市的公司的营收预计将从去年同期的2547万美元下降69.9%,至766.7万美元。* LSEG 分析师对 Spero Therapeutics Inc 的平均预期是每股亏损 36 美分。* 华尔街对 Spero Therapeutics Inc 的 12 个月目标价中位数为 5.00 美元,高于其上次收盘价 1.31 美元。11月8日 - 上一季度业绩。除非另有说明,所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRO","LENZ"],"gpt_icon":0},{"id":"2480858040","title":"Spero Therapeutics, Inc.盘中异动 早盘股价大涨5.93%报1.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480858040","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480858040?lang=zh_cn&edition=full","pubTime":"2024-11-04 23:37","pubTimestamp":1730734628,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日23时37分,Spero Therapeutics, Inc.股票出现异动,股价大幅上涨5.93%。截至发稿,该股报1.25美元/股,成交量9.0553万股,换手率0.17%,振幅7.63%。Spero Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.20%。其相关个股中,Neurogene Inc.、Tenaya Therapeutics, Inc.、Disc Medicine, Inc.涨幅较大,Nls Pharmaceutics Ltd.、Elevai Labs, Inc.、Gri Bio, Inc.较为活跃,换手率分别为263.35%、260.56%、66.87%,振幅较大的相关个股有In8Bio, Inc.、Kazia Therapeutics Limited、Tc Biopharm Plc C/Wts 10/02/2028 ,振幅分别为45.39%、39.13%、31.90%。Spero Therapeutics, Inc.公司简介:Spero Therapeutics Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104233708971a4335&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104233708971a4335&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRO","LENZ"],"gpt_icon":0},{"id":"2479355800","title":"Spero Therapeutics, Inc.盘中异动 大幅跳水5.43%报1.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479355800","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479355800?lang=zh_cn&edition=full","pubTime":"2024-10-31 22:06","pubTimestamp":1730383567,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日22时06分,Spero Therapeutics, Inc.股票出现波动,股价快速下跌5.43%。Spero Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为2.83%。Spero Therapeutics, Inc.公司简介:Spero Therapeutics Inc是一家临床阶段生物制药公司。该公司的候选产品tebipenem pivoxil hydrobromide或tebipenem HBr,是一种口服碳青霉烯类抗生素,用于成人治疗MDR革兰氏阴性菌感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031220607ab8bb886&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031220607ab8bb886&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRO","BK4139","LENZ"],"gpt_icon":0},{"id":"2479347785","title":"Spero Therapeutics, Inc.盘中异动 快速跳水19.85%报1.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479347785","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479347785?lang=zh_cn&edition=full","pubTime":"2024-10-30 21:31","pubTimestamp":1730295106,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日21时31分,Spero Therapeutics, Inc.股票出现异动,股价急速下跌19.85%。Spero Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.30%。其相关个股中,Tharimmune, Inc.、Ensysce Biosciences, Inc.、Gri Bio, Inc.涨幅较大,Tharimmune, Inc.、Ensysce Biosciences, Inc.、Tc Biopharm Plc较为活跃,换手率分别为1736.42%、98.93%、15.89%,振幅较大的相关个股有Tharimmune, Inc.、Ensysce Biosciences, Inc.、Cormedix Inc.,振幅分别为22.66%、11.49%、10.79%。Spero Therapeutics, Inc.公司简介:Spero Therapeutics Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103021314795bd8df3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103021314795bd8df3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","SPRO","BK4139"],"gpt_icon":0},{"id":"2478953969","title":"Spero Therapeutics, Inc.盘中异动 股价大涨5.56%报1.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478953969","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478953969?lang=zh_cn&edition=full","pubTime":"2024-10-26 00:02","pubTimestamp":1729872165,"startTime":"0","endTime":"0","summary":"北京时间2024年10月26日00时02分,Spero Therapeutics, Inc.股票出现异动,股价快速上涨5.56%。截至发稿,该股报1.33美元/股,成交量21.1513万股,换手率0.39%,振幅2.38%。Spero Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.66%。其相关个股中,Iterum Therapeutics Plc、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Immunitybio, Inc.涨幅较大,180 Life Sciences Corp.、Elevai Labs, Inc.、Tc Biopharm Plc较为活跃,换手率分别为816.21%、743.25%、224.31%,振幅较大的相关个股有Qualigen Therapeutics, Inc.、Iterum Therapeutics Plc、Elevai Labs, Inc.,振幅分别为91.58%、90.60%、85.14%。Spero Therapeutics, Inc.公司简介:Spero Therapeutics Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241026000245a1ead8ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241026000245a1ead8ed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","SPRO","BK4139"],"gpt_icon":0},{"id":"2476248518","title":"Spero Therapeutics, Inc.盘中异动 下午盘快速上涨5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476248518","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476248518?lang=zh_cn&edition=full","pubTime":"2024-10-18 01:33","pubTimestamp":1729186408,"startTime":"0","endTime":"0","summary":"北京时间2024年10月18日01时33分,Spero Therapeutics, Inc.股票出现波动,股价快速上涨5.24%。Spero Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.87%。Spero Therapeutics, Inc.公司简介:Spero Therapeutics Inc是一家临床阶段生物制药公司。该公司的候选产品tebipenem pivoxil hydrobromide或tebipenem HBr,是一种口服碳青霉烯类抗生素,用于成人治疗MDR革兰氏阴性菌感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101801332998e3d0e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101801332998e3d0e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","SPRO","BK4139"],"gpt_icon":0},{"id":"2473201420","title":"Spero Therapeutics, Inc.盘中异动 早盘大幅跳水5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2473201420","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473201420?lang=zh_cn&edition=full","pubTime":"2024-10-08 21:31","pubTimestamp":1728394299,"startTime":"0","endTime":"0","summary":"北京时间2024年10月08日21时31分,Spero Therapeutics, Inc.股票出现波动,股价大幅跳水5.38%。Spero Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.29%。其相关个股中,Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Bio-Path Holdings, Inc.、Virios Therapeutics, Inc.涨幅较大,Virios Therapeutics, Inc.、Aditxt, Inc.、Bio-Path Holdings, Inc.较为活跃,换手率分别为2707.00%、1660.81%、1117.40%,振幅较大的相关个股有Virios Therapeutics, Inc.、Tonix Pharmaceuticals Holding Corp.、Entero Therapeutics Inc.,振幅分别为14.29%、13.48%、12.02%。Spero Therapeutics, Inc.公司简介:Spero Therapeutics Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410082131409719ef4a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410082131409719ef4a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","SPRO"],"gpt_icon":0},{"id":"2470803863","title":"Spero Therapeutics, Inc.盘中异动 早盘急速上涨5.47%报1.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470803863","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470803863?lang=zh_cn&edition=full","pubTime":"2024-09-27 23:19","pubTimestamp":1727450347,"startTime":"0","endTime":"0","summary":"北京时间2024年09月27日23时19分,Spero Therapeutics, Inc.股票出现波动,股价快速上涨5.47%。Spero Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.69%。其相关个股中,Nls Pharmaceutics Ltd C/Wts 02/02/2026、Onconetix, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大,Onconetix, Inc.、Seelos Therapeutics, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃,换手率分别为3891.00%、211.89%、122.97%,振幅较大的相关个股有Pasithea Therapeutics Corp C/Wts 12/08/2026 、Cardio Diagnostics Holdings Inc C/Wts To Pur Com、Psyence Biomedical Ltd C/Wts 25/01/2029,振幅分别为167.75%、61.38%、51.69%。Spero Therapeutics, Inc.公司简介:Spero Therapeutics Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240927231907ab66870f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240927231907ab66870f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRO","LENZ"],"gpt_icon":0},{"id":"2460680055","title":"Spero Therapeutics, Inc.盘中异动 急速上涨5.04%报1.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2460680055","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460680055?lang=zh_cn&edition=full","pubTime":"2024-08-19 23:19","pubTimestamp":1724080786,"startTime":"0","endTime":"0","summary":"北京时间2024年08月19日23时19分,Spero Therapeutics, Inc.股票出现波动,股价急速拉升5.04%。Spero Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.31%。其相关个股中,Alzamend Neuro, Inc.、Virax Biolabs Group Limited、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大,Alzamend Neuro, Inc.、Virax Biolabs Group Limited、Tonix Pharmaceuticals Holding Corp.较为活跃,换手率分别为6342.24%、3003.36%、934.40%,振幅较大的相关个股有Alzamend Neuro, Inc.、Virax Biolabs Group Limited、Psyence Biomedical Ltd C/Wts 25/01/2029,振幅分别为405.90%、220.18%、93.47%。Spero Therapeutics, Inc.公司简介:Spero Therapeutics Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240819231946971992bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240819231946971992bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","SPRO"],"gpt_icon":0},{"id":"2458069291","title":"Spero Therapeutics, Inc.2024财年第二财季实现净利润-17.86百万美元,同比减少49.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458069291","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458069291?lang=zh_cn&edition=full","pubTime":"2024-08-12 00:09","pubTimestamp":1723392568,"startTime":"0","endTime":"0","summary":"8月12日,Spero Therapeutics, Inc.公布财报,公告显示公司2024财年第二财季净利润为-17.86百万美元,同比减少49.96%;其中营业收入为6.02百万美元,同比增加663.96%,每股基本收益为-0.33美元。机构评级:截至2024年8月12日,当前有2家机构对Spero Therapeutics, Inc.目标价做出预测,其中目标均价为7.50美元,其中最低目标价为7.00美元,最高目标价为8.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408120009339f22255b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408120009339f22255b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","SPRO"],"gpt_icon":0},{"id":"2457076237","title":"TD Cowen:上调Spero Therapeutics(SPRO.US)评级,由持有调整至买入评级。","url":"https://stock-news.laohu8.com/highlight/detail?id=2457076237","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457076237?lang=zh_cn&edition=full","pubTime":"2024-08-07 00:55","pubTimestamp":1722963343,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","BK4585","LENZ","SPRO","BK4207","BK4566","TD"],"gpt_icon":0},{"id":"2457023647","title":"Spero Therapeutics, Inc.盘中异动 早盘股价大跌5.22%报1.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457023647","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457023647?lang=zh_cn&edition=full","pubTime":"2024-08-06 21:41","pubTimestamp":1722951691,"startTime":"0","endTime":"0","summary":"北京时间2024年08月06日21时41分,Spero Therapeutics, Inc.股票出现波动,股价大幅下挫5.22%。截至发稿,该股报1.27美元/股,成交量10.0056万股,换手率0.19%,振幅7.46%。Spero Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.31%。其相关个股中,Vbi Vaccines, Inc.、Tenax Therapeutics, Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 涨幅较大,Tenax Therapeutics, Inc.、Vbi Vaccines, Inc.、Cns Pharmaceuticals, Inc.较为活跃,换手率分别为905.37%、505.09%、230.95%,振幅较大的相关个股有Vbi Vaccines, Inc.、Tenax Therapeutics, Inc.、Actinium Pharmaceuticals, Inc. ,振幅分别为135.14%、29.11%、27.81%。Spero Therapeutics, Inc.公司简介:Spero Therapeutics Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240806214131968245e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240806214131968245e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","SPRO"],"gpt_icon":0},{"id":"2454072768","title":"Spero Therapeutics, Inc.盘中异动 下午盘快速上涨6.52%报1.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2454072768","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454072768?lang=zh_cn&edition=full","pubTime":"2024-07-26 01:09","pubTimestamp":1721927347,"startTime":"0","endTime":"0","summary":"北京时间2024年07月26日01时09分,Spero Therapeutics, Inc.股票出现异动,股价急速拉升6.52%。Spero Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.45%。其相关个股中,Salarius Pharmaceuticals, Inc.、Psyence Biomedical Ltd.、Geovax Labs Inc C/Wts 29/09/2025涨幅较大,Salarius Pharmaceuticals, Inc.、Psyence Biomedical Ltd.、Exicure, Inc.较为活跃,换手率分别为4704.10%、559.34%、280.64%,振幅较大的相关个股有Psyence Biomedical Ltd.、Exicure, Inc.、Salarius Pharmaceuticals, Inc.,振幅分别为152.48%、132.26%、98.60%。Spero Therapeutics, Inc.公司简介:Spero Therapeutics Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726010907af94232d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726010907af94232d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRO","LENZ"],"gpt_icon":0},{"id":"2452745913","title":"Spero Therapeutics, Inc.盘中异动 临近收盘股价大跌5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452745913","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452745913?lang=zh_cn&edition=full","pubTime":"2024-07-19 04:00","pubTimestamp":1721332830,"startTime":"0","endTime":"0","summary":"北京时间2024年07月19日04时00分,Spero Therapeutics, Inc.股票出现波动,股价快速下跌5.41%。Spero Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为1.91%。其相关个股中,Salarius Pharmaceuticals, Inc.、Silo Pharma, Inc.、Onconetix, Inc.涨幅较大,Salarius Pharmaceuticals, Inc.、Silo Pharma, Inc.、Onconetix, Inc.较为活跃,换手率分别为3563.03%、2836.27%、1350.67%,振幅较大的相关个股有Silo Pharma, Inc.、Salarius Pharmaceuticals, Inc.、Onconetix, Inc.,振幅分别为93.33%、91.50%、90.54%。Spero Therapeutics, Inc.公司简介:Spero Therapeutics Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240719040030941f8694&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240719040030941f8694&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRO","LENZ","BK4139"],"gpt_icon":0},{"id":"2452494913","title":"Spero Therapeutics, Inc.盘中异动 股价大涨5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452494913","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452494913?lang=zh_cn&edition=full","pubTime":"2024-07-17 02:36","pubTimestamp":1721154976,"startTime":"0","endTime":"0","summary":"北京时间2024年07月17日02时36分,Spero Therapeutics, Inc.股票出现波动,股价大幅上涨5.19%。Spero Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.13%。Spero Therapeutics, Inc.公司简介:Spero Therapeutics Inc是一家临床阶段生物制药公司。该公司的候选产品tebipenem pivoxil hydrobromide或tebipenem HBr,是一种口服碳青霉烯类抗生素,用于成人治疗MDR革兰氏阴性菌感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717023617aef9f858&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717023617aef9f858&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRO","LENZ","BK4139"],"gpt_icon":0},{"id":"2450367551","title":"Spero Therapeutics, Inc.盘中异动 临近午盘大幅上涨6.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450367551","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450367551?lang=zh_cn&edition=full","pubTime":"2024-07-11 23:42","pubTimestamp":1720712551,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日23时42分,Spero Therapeutics, Inc.股票出现异动,股价快速上涨6.62%。Spero Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.78%。其相关个股中,Neximmune, Inc.、Geovax Labs Inc C/Wts 29/09/2025、Kazia Therapeutics Limited涨幅较大,Biodexa Pharmaceuticals Plc、Kazia Therapeutics Limited、Cns Pharmaceuticals, Inc.较为活跃,换手率分别为628.62%、581.24%、413.39%,振幅较大的相关个股有Revolution Medicines Inc C/Wts 17/12/2026 、Neximmune, Inc.、Biodexa Pharmaceuticals Plc,振幅分别为149.14%、92.85%、88.60%。Spero Therapeutics, Inc.公司简介:Spero Therapeutics Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711234231941f6531&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711234231941f6531&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","SPRO"],"gpt_icon":0},{"id":"2450734670","title":"Spero Therapeutics, Inc.盘中异动 快速上涨5.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450734670","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450734670?lang=zh_cn&edition=full","pubTime":"2024-07-10 01:19","pubTimestamp":1720545581,"startTime":"0","endTime":"0","summary":"北京时间2024年07月10日01时19分,Spero Therapeutics, Inc.股票出现波动,股价快速拉升5.91%。Spero Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.27%。Spero Therapeutics, Inc.公司简介:Spero Therapeutics Inc是一家临床阶段生物制药公司。该公司的候选产品tebipenem pivoxil hydrobromide或tebipenem HBr,是一种口服碳青霉烯类抗生素,用于成人治疗MDR革兰氏阴性菌感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710011941aef8c0ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710011941aef8c0ff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRO","BK4139","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sperotherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.048},{"period":"1month","weight":-0.063},{"period":"3month","weight":-0.1314},{"period":"6month","weight":-0.1905},{"period":"1year","weight":-0.0165},{"period":"ytd","weight":-0.1905}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Spero Therapeutics, Inc.,前称为Spero Therapeutics,LLC,于2013年12月根据特拉华州的法律成立。该公司是一个多资产,临床阶段的生物制药公司,专注于识别、开发和营销治疗MDR细菌感染的新疗法。该公司还拥有一项名为“潜力平台”的平台技术,他们相信这将使他们开发出能够扩大现有抗生素的范围和效力的药物,包括以前不活跃的抗生素,对抗革兰氏阴性细菌。他们相信,如果成功地开发和批准了他们的新产品,将会对社区和医院环境中治疗MDR感染的患者产生有意义的影响和重要的商业应用。","yearOnYearQuotes":[{"month":1,"riseRate":0.571429,"avgChangeRate":0.068144},{"month":2,"riseRate":0.571429,"avgChangeRate":-0.038645},{"month":3,"riseRate":0.428571,"avgChangeRate":0.002566},{"month":4,"riseRate":0.285714,"avgChangeRate":-0.028483},{"month":5,"riseRate":0.285714,"avgChangeRate":-0.12624},{"month":6,"riseRate":0.428571,"avgChangeRate":-0.016403},{"month":7,"riseRate":0.285714,"avgChangeRate":-0.042117},{"month":8,"riseRate":0.285714,"avgChangeRate":0.04487},{"month":9,"riseRate":0.428571,"avgChangeRate":0.176126},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.040426},{"month":11,"riseRate":0.571429,"avgChangeRate":0.02835},{"month":12,"riseRate":0.428571,"avgChangeRate":0.001993}],"exchange":"NASDAQ","name":"Spero Therapeutics Inc.","nameEN":"Spero Therapeutics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Spero Therapeutics Inc.(SPRO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Spero Therapeutics Inc.(SPRO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Spero Therapeutics Inc.,SPRO,Spero Therapeutics Inc.股票,Spero Therapeutics Inc.股票老虎,Spero Therapeutics Inc.股票老虎国际,Spero Therapeutics Inc.行情,Spero Therapeutics Inc.股票行情,Spero Therapeutics Inc.股价,Spero Therapeutics Inc.股市,Spero Therapeutics Inc.股票价格,Spero Therapeutics Inc.股票交易,Spero Therapeutics Inc.股票购买,Spero Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Spero Therapeutics Inc.(SPRO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Spero Therapeutics Inc.(SPRO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}